Lipid and biochemical changes after low-dose oral contraception

Contraception

Volumn 46, Issue 3, 1992, Pages 227-241

  Loke, Diana F M ^a   Ng, Charles S A ^b   Holck, Susan ^c   Hall, Peter E ^c   Ratnam, Shan S ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; LEVONORGESTREL; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ASIA; BIOLOGY; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE METHODS; DEVELOPING COUNTRIES; DOUBLE-BLIND STUDIES; ETHINYL ESTRADIOL; FAMILY PLANNING; IUD; LEVONORGESTREL; LIPIDS; METABOLIC EFFECTS; ORAL CONTRACEPTIVES; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; SINGAPORE; SOUTHEASTERN ASIA; STUDIES;

ADULT; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PROTEINS; CHOLESTEROL; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL, COMBINED; DOUBLE-BLIND METHOD; ETHINYL ESTRADIOL; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMAN; INTRAUTERINE DEVICES; LEVONORGESTREL; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; NORETHINDRONE; PARITY; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRIGLYCERIDES;

EID: 0026697441     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(92)90004-D     Document Type: Article

References (29)

1. Metabolic investigations in women taking 30 μg ethinyl estradiol and 150 μg d-norgestrel
2. Effect of contraceptive steroids on serum lipids
3. Comparison of effects of different oral contraceptive formulations on carbohydrate and lipid metabolism
4. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring I. Carbohydrate metabolism and liver function
5. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors
6. Enzymatic determination of glucose and fructose simultaneously
7. Quantitative determination of serum triglycerides by use of enzymes
8. Comparison of two new developed enzymatic cholesterol-colour tests on Auto-Analyzer-systems with other cholesterol tests (Abstract)
9. Multiple automatic sequential analysis
10. Influence of reagent quality and reaction conditions on the determination of serum albumin by the bromocresol green dye-binding method
11. Response of the SMA12/60 and AutoAnalyzer II inverse calorimetry and 340 nm photometry
12. The measurement of amniotic fluid bilirubin by the method of Jendrassik and Grof
13. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
14. Estimation of LDL-cholesterol concentration without use of the preparative ultracentrifuge
15. The effect of estrogen on carbohydrate metabolism: glucose, insulin and growth hormone studies on one-hundred-and-seventy-one women ingesting Premarin, mestranol and ethinyl estradiol for 6 months
16. Urinary excretion of different corticosteroid-metabolites in oral contraception and pregnancy
17. Effects of combined and low-dose gestagen oral contraceptives on plasma lipids including individual phospholipids
18. Lipo-protein changes may be minimized by proper composition of a combined oral contraceptive
19. Effects of seven low-dose combined oral contraceptives on high density lipoprotein subfractions
20. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring
21. Effects of the estrogenicity of levonorgestrel/ethinyl estradiol combinations on the lipoprotein status
22. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism
23. Oral contraceptives and liver damage
24. Oral contraception and liver function tests
25. Liver function tests during intake of contraceptive tablets in pre-menopausal women
26. Effect of estrogen/progestin potency on clinical chemistry measures. The Lipid Research Clinics Program Prevalence Study
27. Effect of estrogen/progestin potency on clinical chemistry measures. The Lipid Research Clinics Program Prevalence Study